Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Shah, Jinesh N ^a   Shao, Genze ^a,b   Hei, Tom K ^a   Zhao, Yongliang ^a  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; GENOMIC DNA; TRANSFORMING GROWTH FACTOR BETA1; DNA; TGFB1 PROTEIN, HUMAN;

ACCURACY; ADULT; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER LOCALIZATION; CLINICAL FEATURE; CONTROLLED STUDY; CPG ISLAND; DNA ISOLATION; DNA METHYLATION; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; PHENOTYPE; POLYMERASE CHAIN REACTION; PROCESS OPTIMIZATION; PROGNOSIS; PROMOTER REGION; PROSTATE CANCER; PROSTATECTOMY; BIOSYNTHESIS; GENETICS; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; METASTASIS; METHODOLOGY; PATHOLOGY; PROSTATE TUMOR;

CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; DNA, NEOPLASM; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 55049137801     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-284     Document Type: Article

References (32)

1. Jemal A Siegel R Ward E Murray T Xu J Thun MJ Cancer statistics, 2007 CA Cancer J Clin 2007, 57(1):43-66. 17237035
2. Palapattu GS Sutcliffe S Bastian PJ Platz EA De Marzo AM Isaacs WB Nelson WG Prostate carcinogenesis and inflammation: Emerging insights Carcinogenesis 2005, 26(7):1170-1181. 10.1093/carcin/bgh317 15498784
3. Kerr KM Galler JS Hagen JA Laird PW Laird-Offringa IA The role of DNA methylation in the development and progression of lung adenocarcinoma Dis Markers 2007, 23(1-2):5-30. 17325423
4. Hegeman RB Liu G Wilding G McNeel DG Newer therapies in advanced prostate cancer Clin Prostate Cancer 2004, 3(3):150-156. 15636681
5. Li LC Carroll PR Dahiya R Epigenetic changes in prostate cancer: implication for diagnosis and treatment J Natl Cancer Inst 2005, 97(2):103-115. 15657340
6. Catto JW Azzouzi AR Rehman I Feeley KM Cross SS Amira N Fromont G Sibony M Cussenot O Meuth M Hamdy FC Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma J Clin Oncol 2005, 23(13):2903-2910. 10.1200/ JCO.2005.03.163 15753461
7. Hoon DS Spugnardi M Kuo C Huang SK Morton DL Taback B Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients Oncogene 2004, 23(22):4014-4022. 10.1038/sj.onc.1207505 15064737
8. Jones PA Baylin SB The fundamental role of epigenetic events in cancer Nat Rev Genet 2002, 3(6):415-428. 12042769
9. Bulinski JC McGraw TE Gruber D Nguyen HL Sheetz MP Overexpression of MAP4 inhibits organelle motility and trafficking in vivo J Cell Sci 1997, 110(Pt 24):3055-3064. 9365275
10. Lee WH Morton RA Epstein JI Brooks JD Campbell PA Bova GS Hsieh WS Isaacs WB Nelson WG Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis Proc Natl Acad Sci USA 1994, 91(24):11733-11737. 45306 7972132 10.1073/pnas.91.24.11733
11. Jarrard DF Bova GS Ewing CM Pin SS Nguyen SH Baylin SB Cairns P Sidransky D Herman JG Isaacs WB Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer Genes Chromosomes Cancer 1997, 19(2):90-96. 10.1002/ (SICI)1098-2264(199706)19:2<90::AID-GCC4>3.0.CO;2-V 9171999
12. Jeronimo C Henrique R Hoque MO Ribeiro FR Oliveira J Fonseca D Teixeira MR Lopes C Sidransky D Quantitative RARbeta2 hypermethylation: A promising prostate cancer marker Clin Cancer Res 2004, 10(12 Pt 1):4010-4014. 10.1158/1078-0432.CCR-03-0643 15217932
13. Kuzmin I Gillespie JW Protopopov A Geil L Dreijerink K Yang Y Vocke CD Duh FM Zabarovsky E Minna JD Rhim JS Emmert-Buck MR Linehan WM Lerman MI The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells Cancer Res 2002, 62(12):3498-3502. 12067994
14. Skonier J Neubauer M Madisen L Bennett K Plowman GD Purchio AF cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta DNA Cell Biol 1992, 11(7):511-522. 1388724
15. Zhao YL Piao CQ Hei TK Downregulation of Betaig-h3 gene is causally linked to tumorigenic phenotype in asbestos treated immortalized human bronchial epithelial cells Oncogene 2002, 21(49):7471-7477. 10.1038/ sj.onc.1205891 12386809
16. Shao G Berenguer J Borczuk AC Powell CA Hei TK Zhao Y Epigenetic inactivation of Betaig-h3 gene in human cancer cells Cancer Res 2006, 66(9):4566-4573. 10.1158/0008-5472.CAN-05-2130 16651406
17. Bolla M van Poppel H Collette L van Cangh P Vekemans K Da Pozzo L de Reijke TM Verbaeys A Bosset JF van Velthoven R Maréchal JM Scalliet P Haustermans K Piérart M Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911) Lancet 2005, 366(9485):572-578. 10.1016/S0140-6736(05)67101-2 16099293
18. Thompson IM Jr Tangen CM Paradelo J Lucia MS Miller G Troyer D Messing E Forman J Chin J Swanson Canby-Hagino E Crawford ED Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial JAMA 2006, 296(19):2329-2335. 10.1001/jama.296.19.2329 17105795
19. Stetler-Stevenson WG Aznavoorian S Liotta LA Tumor cell interactions with the extracellular matrix during invasion and metastasis Annu Rev Cell Biol 1993, 9:541-573. 10.1146/annurev.cb.09.110193.002545 8280471
20. Kim JE Jeong HW Nam JO Lee BH Choi JY Park RW Park JY Kim IS Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin J Biol Chem 2002, 277(48):46159-46165. 10.1074/ jbc.M207055200 12270930
21. Nam JO Kim JE Jeong HW Lee SJ Lee BH Choi JY Park RW Park JY Kim IS Identification of the alphavbeta3 integrin-interacting motif of betaig-h3 and its anti-angiogenic effect J Biol Chem 2003, 278(28):25902-25909. 10.1074/jbc.M300358200 12704192
22. Jeong HW Kim IS TGF-beta1 enhances betaig-h3-mediated keratinocyte cell migration through the alpha3beta1 integrin and PI3K J Cell Biochem 2004, 92(4):770-780. 10.1002/jcb.20110 15211574
23. Billings PC Herrick DJ Kucich U Engelsberg BN Abrams WR Macarak EJ Rosenbloom J Howard PS Extracellular matrix and nuclear localization of beta ig-h3 in human bladder smooth muscle and fibroblast cells J Cell Biochem 2000, 79(2):261-273. 10.1002/ 1097-4644(20001101)79:2<261::AID-JCB90>3.0.CO;2-# 10967553
24. Story MT Hopp KA Meier DA Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells Prostate 1996, 28(4):219-226. 10.1002/ (SICI)1097-0045(199604)28:4<219::AID-PROS2>3.0.CO;2-8 8602397
25. Jetten AM Vollberg TM Nervi C George MD Positive and negative regulation of proliferation and differentiation in tracheobronchial epithelial cells Am Rev Respir Dis 1990, 142(6 Pt 2):S36-39. 2252274
26. Turley RS Finger EC Hempel N How T Fields TA Blobe GC The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer Cancer Res 2007, 67(3):1090-1098. 10.1158/ 0008-5472.CAN-06-3117 17283142
27. Teicher BA Malignant cells, directors of the malignant process: Role of transforming growth factor-beta Cancer Metastasis Reviews 2001, 20(1-2):133-143. 11831642
28. Ma C Rong Y Radiloff DR Datto MB Centeno B Bao S Cheng AW Lin F Jiang S Yeatman TJ Wang XF Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation Genes Dev 2008, 22(3):308-321. 2216691 18245446 10.1101/gad.1632008
29. Genini M Schwalbe P Scholl FA Schafer BW Isolation of genes differentially expressed in human primary myoblasts and embryonal rhabdomyosarcoma Int J Cancer 1996, 66(4):571-577. 10.1002/ (SICI)1097-0215(19960516)66:4<571::AID-IJC24>3.0.CO;2-9 8635876
30. Zhao Y El-Gabry M Hei TK Loss of Betaig-h3 protein is frequent in primary lung carcinoma and related to tumorigenic phenotype in lung cancer cells Mol Carcinog 2006, 45(2):84-92. 10.1002/mc.20167 16329146
31. Calaf GM Echiburu-Chau C Zhao YL Hei TK BigH3 protein expression as a marker for breast cancer Int J Mol Med 2008, 21(5):561-568. 18425347
32. Becker J Volland S Noskova I Schramm A Schweigerer LL Wilting J Keratoepithelin reverts the suppression of tissue factor pathway inhibitor 2 by MYCN in human neuroblastoma: A mechanism to inhibit invasion Int J Oncol 2008, 32(1):235-240. 18097563